FDA Appropriations In Senate Largely Matches House, Not That It Will Help
This article was originally published in The Pink Sheet Daily
Executive Summary
Relatively tepid approach to user fees is the same between the committees in both chambers, and while the funding level for the agency is about $67 million less in the House proposal, the larger political dynamic makes a continuing resolution seem inevitable.